KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Long-Term Deferred Tax: 2016-2017

Historic Long-Term Deferred Tax for Idexx Laboratories (IDXX) over the last 2 years, with Dec 2017 value amounting to $7.7 million.

  • Idexx Laboratories' Long-Term Deferred Tax rose 67.43% to $9.8 million in Q1 2018 from the same period last year, while for Mar 2018 it was $9.8 million, marking a year-over-year increase of 67.43%. This contributed to the annual value of $7.7 million for FY2017, which is 34.89% up from last year.
  • Idexx Laboratories' Long-Term Deferred Tax amounted to $7.7 million in FY2017, which was up 34.89% from $5.7 million recorded in FY2016.
  • In the past 5 years, Idexx Laboratories' Long-Term Deferred Tax ranged from a high of $7.7 million in FY2017 and a low of $5.7 million during FY2016.
  • Its 2-year average for Long-Term Deferred Tax is $6.7 million, with a median of $6.7 million in 2016.
  • Data for Idexx Laboratories' Long-Term Deferred Tax shows a peak YoY spiked of 34.89% (in 2017) over the last 5 years.
  • Over the past 2 years, Idexx Laboratories' Long-Term Deferred Tax (Yearly) stood at $5.7 million in 2016, then skyrocketed by 34.89% to $7.7 million in 2017.